Boston Scientific (BSX) Non-Current Debt (2009 - 2026)

Boston Scientific has disclosed Non-Current Debt across 18 years of filings, most recently posting $10.9 billion for Q2 2026.

• In Q2 2026, Non-Current Debt fell 1.73% year-over-year to $10.9 billion; the TTM figure through Jun 2026 stood at $10.9 billion (down 1.73% YoY), while the FY2025 annual figure was $11.1 billion, up 24.19% from the prior year.
• Non-Current Debt came in at $10.9 billion for Q2 2026 at Boston Scientific, down from $11.0 billion in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $11.1 billion in Q4 2025 to a low of $8.4 billion in Q3 2023.
• Average Non-Current Debt over 5 years is $9.5 billion, with a median of $9.0 billion recorded in 2022.
• Year-over-year, Non-Current Debt dropped 6.31% in 2023 and increased 24.19% in 2025.
• Over 5 years, Non-Current Debt stood at $8.9 billion in 2022, then dropped by 3.86% to $8.6 billion in 2023, then grew by 4.63% to $9.0 billion in 2024, then gained by 24.19% to $11.1 billion in 2025, then slipped by 1.99% to $10.9 billion in 2026.
• Per Business Quant data, the three most recent Non-Current Debt figures were $10.9 billion in Q2 2026, $11.0 billion in Q1 2026, and $11.1 billion in Q4 2025.